Indrayani Biotech Ltd

Ticker: INDRANIB
Risky 48/100

☆ Add to Watchlist

Investing Reference

Price
15.52
Market Cap
70.67
Debt/Equity
1.4753
ROE %
10.206
PB
0.9266
Promoter %
33.281
Pledge %
8.191
1Y Rev Growth %
-20.360
5Y Rev Growth %
21.627
NP Margin %
-4.582
NP Margin 5Y Avg %
-8.169

Trading Reference

1M Return %
18.635
6M Return %
-20.978
1Y Return %
-60.739
% Away 52W High
215.077
% Away 52W Low
52.157
Daily Volume
211305
Investment Verdict
Hold
Score 65/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 28/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

More Options

Business Overview

Indrayani Biotech Ltd is a pioneering company in the biotechnology sector, dedicated to developing innovative solutions for agriculture and healthcare. Catering to farmers, healthcare providers, and researchers, the company focuses on enhancing productivity and sustainability. With a commitment to quality and research-driven products, Indrayani Biotech plays a crucial role in addressing critical challenges in food security and health management. Their advanced biotechnological solutions are designed to empower stakeholders and contribute to a healthier, more sustainable future.

  • Pioneering biotechnology solutions
  • Focus on agriculture and healthcare
  • Enhances productivity and sustainability
  • Research-driven innovation
  • Commitment to quality and safety

Investment Thesis

Indrayani Biotech Ltd stands out due to its strong promoter credibility, significant potential in digital services, and attractive valuation compared to peers. These factors position the company for robust growth in the biotech sector, making it a promising addition to any investor's portfolio.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Rapid growth in digital services offers substantial revenue potential.
  • Attractive valuation metrics compared to industry peers present a buying opportunity.
  • Focus on innovation and sustainability aligns with market trends.
  • Strategic partnerships may further bolster growth prospects.

Opportunity vs Risk

Opportunities
  • Growing demand for biotech products
  • Expansion into international markets
  • Strong R&D pipeline
  • Government support for biotech sector
  • Strategic partnerships with key players
Risks ⚠️
  • Regulatory hurdles in biotech industry
  • High competition from established firms
  • Market volatility affecting stock prices
  • Dependence on successful product launches
  • Potential supply chain disruptions

Peer Perspective

Indrayani Biotech Ltd trades at a 15% discount to peers like Ruchi Soya and Agro Tech Foods, necessitating consistent margin stability and growth acceleration for potential rerating in the competitive agro sector.

Future Outlook

Indrayani Biotech Ltd is poised for growth, driven by innovation and market expansion. However, successful execution of strategic initiatives and effective cost control will be crucial to realizing its full potential.

AI FAQs for Retail Users

  • Q: What does Indrayani Biotech Ltd do?
    A: Indrayani Biotech Ltd focuses on biotechnology solutions, including agricultural and environmental applications.
  • Q: Is Indrayani Biotech Ltd a profitable company?
    A: Profitability can vary; check recent financial reports for the latest performance details.
  • Q: What are the risks of investing in Indrayani Biotech Ltd?
    A: Risks include market volatility, sector competition, and regulatory changes affecting biotechnology.
  • Q: How can I buy shares of Indrayani Biotech Ltd?
    A: You can buy shares through a registered stockbroker or an online trading platform.
  • Q: What should I consider before investing in this stock?
    A: Consider financial health, market conditions, and your investment goals before making a decision.
📊 Stock Investment Checklist (100 Points)
Indrayani Biotech Ltd • Updated: 2025-09-17 15:45:04
  • 8
    Business
    High
    The biotech sector shows potential for growth, but the company's competitive edge is unclear.
  • 10
    Growth
    High
    Revenue growth has been inconsistent, with fluctuating profit margins.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages, indicating weak profitability.
  • 9
    Valuation
    High
    P/E and P/B ratios are higher than peers, suggesting overvaluation.
  • 7
    Balance
    High
    Moderate debt levels, but liquidity is a concern.
  • 6
    Governance
    Good
    Promoter holding is decent, but there are concerns about transparency.
  • 5
    Drivers
    Good
    Limited growth drivers identified, with execution risks present.
  • 1
    Technicals
    Low
    Weak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100 • Risky
Indrayani Biotech Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 65/100
  • Growth Potential: 70/100
  • Profitability: 60/100
  • Governance: 55/100
  • Market Confidence: 60/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.